Background And Aims The serological responses after severe acute respiratory syndrome
coronavirus 2 vaccination may be attenuated in immunocompromised individuals. The study …

The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …

Since the late 1990s, tumor necrosis factor alpha (TNF-α) inhibitors (anti-TNFs) have
revolutionized the therapy of immune-mediated inflammatory diseases (IMIDs) affecting the …

Immunocompromised individuals and particularly those with hematologic malignancies are
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …

51: 1149–59. 7 Blais P, Husain N, Kramer JR, Kowalkowski M, ElSerag H, Kanwal F.
Nonalcoholic fatty liver disease is underrecognized in the primary care setting. AM J …

Simple Summary Cancer patients are considered a high-risk group for infectious diseases
including COVID-19. The protective effects of vaccination are unclear in oncologic patients …

Objectives: We prospectively compared the postvaccination immunity to messenger
ribonucleic acid BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The technological process of production of biosimilars determines the degree of biosimilarity
to the original biological drug. In particular, the focus is on the similarity of immunogenic …

Inflammatory bowel diseases (IBD), including Crohn's disease, ulcerative colitis, and
unclassified inflammatory bowel disease, are a group of chronic, immune mediated …

Introduction: The Coronavirus Disease 2019 (COVID-19) pandemic has been caused by the
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The most important …